14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CTRV
Delisted

ContraVir Pharmaceuticals Inc Stock Predictions

$1.23
+0 (+0%)
At Close: May 27, 2022
Currently predicting for Thu, 25 Apr 2024

CTRV Predictions History

2 years ago
JS predicted that CTRV for 2021-06-28 is going $2.25 (4.65%)

2 years ago
hpesig02.245589 predicted that CTRV for 2021-06-28 is going $2.26 (0.00%)

Rank:

4 years ago
JS predicted that CTRV for 2019-06-18 is going $10.02 (89.06%)

4 years ago
Joseph.Charles.Julian.113679 predicted that CTRV for 2019-06-18 is going $17.00 (75.08%)

Rank:

4 years ago
PumpTheseNumbers predicted that CTRV for 2019-05-20 is going $0.109 (-7.94%)

4 years ago
Sarah.Fitzpatrick.109128 predicted that CTRV for 2019-05-20 is going $0.113 (-3.00%)

Rank:

4 years ago
PumpTheseNumbers predicted that CTRV for 2019-05-09 is going $0.110 (-20.28%)

4 years ago
JS predicted that CTRV for 2019-05-08 is going $0.132 (3.04%)

4 years ago
PumpTheseNumbers predicted that CTRV for 2019-05-08 is going $0.134 (4.61%)

4 years ago
NameNotImportant predicted that CTRV for 2019-05-06 is going $0.128 (-12.63%)

Click to get the best stock tips daily for free!

About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. Contr... CTRV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT